APA (7th ed.) Citation

Falloon, J., Piscitelli, S., Vogel, S., Sadler, B., Mitsuya, H., Kavlick, M. F., . . . Masur, H. (2000). Combination Therapy with Amprenavir, Abacavir, and Efavirenz in Human Immunodeficiency Virus (HlV)-Infected Patients Failing a Protease-Inhibitor Regimen: Pharmacokinetic Drug Interactions and Antiviral Activity. Clinical Infectious Diseases, 30(2), 313. https://doi.org/10.1086/313667

Chicago Style (17th ed.) Citation

Falloon, Judith, et al. "Combination Therapy with Amprenavir, Abacavir, and Efavirenz in Human Immunodeficiency Virus (HlV)-Infected Patients Failing a Protease-Inhibitor Regimen: Pharmacokinetic Drug Interactions and Antiviral Activity." Clinical Infectious Diseases 30, no. 2 (2000): 313. https://doi.org/10.1086/313667.

MLA (9th ed.) Citation

Falloon, Judith, et al. "Combination Therapy with Amprenavir, Abacavir, and Efavirenz in Human Immunodeficiency Virus (HlV)-Infected Patients Failing a Protease-Inhibitor Regimen: Pharmacokinetic Drug Interactions and Antiviral Activity." Clinical Infectious Diseases, vol. 30, no. 2, 2000, p. 313, https://doi.org/10.1086/313667.